Healthcare social media researchers could learn a lot from startups, pharma
The study results suggest it may be possible to link social media content to health outcomes.
The study results suggest it may be possible to link social media content to health outcomes.
Turing isn't just buying drugs and bumping up prices. It is actually putting a focus on new drugs, which is exemplified with its recent investigational new drug application.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
The newly approved therapy comes with a hefty price tag.
Akari Therapeutics just got a big boost with additional proceeds due to private placement.
Anyone can have their hand in the ethical minefield of Big Pharma with this new sims game.
Even as the understanding of science continues to progress, that doesn't necessarily mean it makes things easier for drug manufacturers.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
How is drug effectiveness determined? How do formulary designs, coverage decisions by PBMs, and third party reviews assess the efficacy and effectiveness of drugs?
With helpful online resources and even a new mobile app, consumers can find ways to not let rising prescription drug costs take them down.
Although medication can often be effective for those with psychiatric disorders, the use of brain games could eventually be a possible, safer alternative.
The FDA has approved a 3D-printed drug designed to treat epileptics, OraSure Technologies' Ebola test gets emergency use authorization.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Shire adds to eye treatment portfolio with biotherapeutic deal and FDA issues safety alert for a Hospira infusion pump over concerns that it is vulnerable to a cyberattack.
Amgen is looking for a senior counsel as part of an expansion of its digital health team. Guess who they contacted?
Between 1.5 and 3 percent of all drug purchases made in America are made through 340B.
CMS report on health spending points to escalating prescription drug prices as a significant factor, FDA releases draft guidance for advancing the quality and supply of medications.
Allergan is the center of attention in a couple of stories this morning with anti-depressant acquisition and a sale of its generics business to Teva.